Name | Type | Posted | Actions |
|---|---|---|---|
75F40126Q134073 Sol.pdf | Jun 9, 2026 |
Luminex magnetic carboxylated microsphere beads, or equivalent
The Food and Drug Administration is seeking quotes for Luminex magnetic carboxylated microsphere beads or equivalent products to support the Center for Biologics Evaluation and Research. This solicitation, 75F40126Q134073, is a full and open competition for 42 distinct line items of MagPlex bead sets used in multiplex applications. The procurement is conducted under NAICS code 325413, In-Vitro Diagnostic Substance Manufacturing. Evaluation will be based on the Lowest Priced Technically Acceptable criteria. Deliveries are required at the agency facility in Silver Spring, Maryland. Submissions must include technical specifications for surface chemistry and magnetic properties, along with an Accessibility Conformance Report and a Letter of Supply for resellers. The FDA Center for Biologics Evaluation and Research is procuring Luminex magnetic carboxylated microsphere beads or functional equivalents under solicitation 75F40126Q134073. These microspheres support fluorescent magnetic immunoassays used to evaluate antigen-specific immune responses for viruses such as RSV and influenza.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.
Contact and place of performance
Suzanne Martella
Not specified
See attached solicitatin/RFQ for Luminex magnetic carboxylated microsphere beads, or equivalent.